Correspondence on "Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions" by Lavelle et al
Genet Med
.
2022 Dec;24(12):2595-2596.
doi: 10.1016/j.gim.2022.08.030.
Epub 2022 Sep 22.
Authors
Scott D Grosse
1
,
James M Gudgeon
2
Affiliations
1
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: SGG4@CDC.GOV.
2
Salt Lake City, UT.
PMID:
36129466
PMCID:
PMC9768457
DOI:
10.1016/j.gim.2022.08.030
No abstract available
Publication types
Letter
Comment
MeSH terms
Base Sequence
Child
Cost-Benefit Analysis
Exome Sequencing
Exome* / genetics
Humans
Rare Diseases* / diagnosis
Rare Diseases* / genetics
Sequence Analysis, DNA
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States